GLP-1 receptor agonists, cancer risk and questionable significance

Published Date: 29 Aug 2025

Research led by the Indiana University School of Medicine and the University of Florida reports an association between taking GLP-1 receptor agonists and lower overall cancer risk in adults with obesity or overweight, with ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GLP-1 receptor agonists, cancer risk and questionable significance

2.

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.

3.

The risk of cancer is decreased by following international health recommendations.

4.

AI is equally capable of reading breast cancer scans as human radiologists.

5.

Discovery of estrogen receptor 'switches' may aid breast cancer treatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot